Tag: new program
David Brooks: The New Old Age
This article was featured in One Story to Read Today, a newsletter in which our editors recommend a single must-read from The Atlantic, Monday through Friday. Sign up for it here.
Anne Kenner worked for many years as a federal prosecutor, first in the Eastern District of New York, and then in the Northern District of California, trying mobsters and drug dealers. “I like the hairy edge,” she told me. Her job was meaningful to her; it made
Are Sports Worth the Risks?
This is an edition of Up for Debate, a newsletter by Conor Friedersdorf. On Wednesdays, he rounds up timely conversations and solicits reader responses to one thought-provoking question. Later, he publishes some thoughtful replies. Sign up for the newsletter here.
Question of the Week
Earlier this week, the NFL player Damar Hamlin’s heart stopped on the field after a violent collision with another player; a mountain climber died after an avalanche on Britain’s highest mountain; and Cedars-Sinai Medical Center in
America’s Drug-Approval System Is Unsustainable
The byzantine world of pharmaceutical regulation has recently broken into the public consciousness, causing a bit of a panic. Aducanumab—the first new Alzheimer’s treatment in nearly two decades—was approved by the Food and Drug Administration on June 7 despite scant evidence of benefit, and against the nearly unanimous advice of the agency’s expert advisers. Op-eds called the decision, which could trigger billions of dollars in new government spending, a “false hope,” “bad medicine,” and “a new low.” (FDA officials have